Legend Biotech (LEGN) EBT (2019 - 2025)
Legend Biotech (LEGN) posted EBT of -$19.6 million for Q4 2025, up 49.84% on a QoQ basis from -$39.1 million in Q3 2025, and down 148.28% year-over-year from $40.6 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of EBT data on file, last reported at -$19.6 million in Q4 2025.
- In Q4 2025, EBT fell 148.28% year-over-year to -$19.6 million; the TTM figure through Dec 2025 stood at -$282.6 million (down 634.64% YoY), while the FY2025 annual figure was -$282.6 million, down 78.75% from the prior year.
- EBT advanced to -$19.6 million in Q4 2025, from -$39.1 million in the prior quarter.
- Across five years, EBT topped out at $59.8 million in Q1 2024 and bottomed at -$198.8 million in Q2 2023.
- A 5-year average of -$79.6 million and a median of -$90.0 million in 2021 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT slumped 33858.75% — and 2024, when it soared 153.4%.
- Year by year, EBT stood at -$88.3 million in 2021, then plunged by 53.65% to -$135.7 million in 2022, then declined by 8.17% to -$146.8 million in 2023, then soared by 127.65% to $40.6 million in 2024, then tumbled by 148.28% to -$19.6 million in 2025.
- The last three EBT figures came in at -$19.6 million (Q4 2025), -$39.1 million (Q3 2025), and -$124.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.70 Mn |
| Sep 30, 2025 | -39.07 Mn |
| Jun 30, 2025 | -124.80 Mn |
| Mar 31, 2025 | 99.13 Mn |
| Dec 31, 2024 | 40.60 Mn |
| Sep 30, 2024 | -120.89 Mn |
| Jun 30, 2024 | -17.97 Mn |
| Mar 31, 2024 | 59.79 Mn |
| Dec 31, 2023 | -146,812.00 |
| Sep 30, 2023 | -62.50 Mn |
| Jun 30, 2023 | -198.84 Mn |
| Mar 31, 2023 | 111.97 Mn |
| Dec 31, 2022 | -135.72 Mn |
| Sep 30, 2022 | -84.80 Mn |
| Jun 30, 2022 | -193.07 Mn |
| Mar 31, 2022 | -32.13 Mn |
| Dec 31, 2021 | -88.33 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -91.58 Mn |
| Mar 31, 2021 | -94,603.00 |
| Dec 31, 2020 | -57.76 Mn |
| Sep 30, 2020 | -67.05 Mn |
| Jun 30, 2020 | -134.88 Mn |
| Mar 31, 2020 | -47.94 Mn |
| Dec 31, 2019 | -61.68 Mn |
| Sep 30, 2019 | -27.79 Mn |
| Jun 30, 2019 | -28.47 Mn |